Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Centessa Pharmaceuticals PLC Sponsored ADR (CNTA) had Free Cash Flow per Share of $-1.43 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-66.16M |
|
-- |
|
-- |
|
$68.47M |
|
$-68.47M |
|
$1.79M |
|
$-66.69M |
|
$-66.69M |
|
$-66.16M |
|
$-66.16M |
|
$-66.16M |
|
$-66.16M |
|
$-68.47M |
|
$-67.95M |
|
135.72M |
|
135.72M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$367.88M |
|
$0.81M |
|
$319.62M |
|
$687.50M |
|
$42.94M |
|
$110.09M |
|
$117.70M |
|
$160.63M |
|
$526.86M |
|
$526.86M |
|
$526.86M |
|
149.23M |
|
| Cash Flow Statement Financials | |
$-193.82M |
|
$-418.53M |
|
$291.53M |
|
$383.22M |
|
$61.95M |
|
$-321.27M |
|
$30.96M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.57 |
|
-- |
|
-- |
|
0.17 |
|
0.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-194.19M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.56% |
|
-12.56% |
|
-9.62% |
|
-10.39% |
|
$3.53 |
|
|
Free Cash Flow per Share |
$-1.43 |
$-1.43 |
|